HealthCare Global Enterprises Limited has announced the divestment of its entire equity stake in BACC Health Care Private Limited to Inviga Healthcare Fund I for a total consideration of INR 37.64 crore. This strategic move is part of the company’s objective to focus on its core cancer care services and optimize capital allocation. The transaction is expected to be completed within 4-5 weeks and has been approved on an arm’s length basis.
Strategic Business Realignment
HealthCare Global Enterprises Limited (HCG) has decided to exit its fertility and reproductive healthcare business. The company entered into a Share Purchase Agreement on May 19, 2026, to sell its entire stake in BACC Health Care Private Limited. By shedding this non-core asset, the company aims to enhance operational focus and reinvest resources into high-growth areas, specifically its primary business of cancer services.
Transaction Details and Valuation
The total deal value is set at INR 37,64,44,788. The payment structure includes an initial consideration of INR 28,23,33,591 payable on the date of closing, with the remaining INR 9,41,11,197 to be paid as deferred consideration within 18 months. The valuation for this transaction was determined by an independent third-party valuer following a competitive bidding process.
Governance and Buyer Profile
The buyer is Inviga Healthcare Fund I. It is noteworthy that Dr. B.S. Ajaikumar, the Promoter and Non-Executive Chairman of HCG, serves as the Sponsor of the fund and controls its investment manager. Given this relationship, the transaction was treated as a related party deal, ensuring it was conducted strictly on an arm’s length basis following approvals from the company’s Audit Committee and Board of Directors.
Financial Impact
For the financial year ended March 31, 2026, BACC contributed INR 60.45 crore to the company’s revenue from operations, representing approximately 4.45% of HCG’s standalone revenue. The unit’s net worth stood at INR 17.53 crore, accounting for 1.09% of the company’s total net worth.
Source: BSE
